Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 347329)

Published in Proc Natl Acad Sci U S A on December 01, 1982

Authors

R A Roth, D J Cassell, K Y Wong, B A Maddux, I D Goldfine

Articles citing this

Membrane receptors for bacterial toxins. Microbiol Rev (1983) 2.41

Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci U S A (1986) 1.94

Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J (1986) 1.87

Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80

Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1985) 1.66

Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48

Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J (1989) 1.40

Protein kinase activity of the insulin receptor. Biochem J (1986) 1.31

Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc Natl Acad Sci U S A (1996) 1.18

Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci U S A (1987) 1.15

Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem J (1987) 1.09

Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1987) 1.05

Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats. J Clin Invest (1983) 1.05

Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody. J Clin Invest (1984) 1.00

The receptor for insulin-like growth factor II mediates an insulin-like response. EMBO J (1987) 0.96

Linking functional domains of the human insulin receptor with the bacterial aspartate receptor. Proc Natl Acad Sci U S A (1986) 0.94

Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci U S A (1992) 0.92

A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem J (1992) 0.91

Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo. J Biol Chem (2009) 0.91

Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta. Biochem J (1989) 0.86

Monoclonal antibodies to the beta-adrenergic receptor: modulation of catecholamine-sensitive adenylate cyclase by the antibody. Arch Dermatol Res (1986) 0.85

Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor. Proc Natl Acad Sci U S A (1988) 0.84

Analysis of insulin receptors on human lymphoblastoid cell lines by flow cytometry. Diabetologia (1984) 0.82

Secretion of the extracellular domain of the human insulin receptor from insect cells by use of a baculovirus vector. Biochem J (1989) 0.80

Analysis of the insulin receptor by anti-receptor antibodies and flow cytometry. Proc Natl Acad Sci U S A (1984) 0.80

Immunohistochemical study of beta-adrenergic receptors in the psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody. Arch Dermatol Res (1987) 0.78

Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes. J Clin Invest (1988) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem (1964) 21.04

Production of monoclonal antibodies: strategy and tactics. J Immunol Methods (1980) 9.28

Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Proc Natl Acad Sci U S A (1978) 3.15

Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science (1975) 2.97

The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem (1982) 2.62

Characteristics of the human lymphocyte insulin receptor. J Biol Chem (1973) 2.61

Antibodies to purified insulin receptor have insulin-like activity. Science (1978) 2.58

The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. J Biol Chem (1980) 2.51

Insulin receptor: covalent labeling and identification of subunits. Proc Natl Acad Sci U S A (1979) 2.24

Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci U S A (1980) 2.15

Binding and degradation of 125I-labelled insulin by isolated rat fat cells. Biochim Biophys Acta (1973) 2.14

Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem (1981) 1.90

Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action. J Clin Invest (1977) 1.85

Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci U S A (1981) 1.72

Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations. Biochemistry (1980) 1.71

The subunit structure of rat liver insulin receptor. Antibodies directed against the insulin-binding subunit. J Biol Chem (1980) 1.57

Purification and properties of the human placental insulin receptor. J Biol Chem (1981) 1.57

Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody. J Biol Chem (1980) 1.54

Purification and properties of insulin receptors from rat liver membranes. Biochem Biophys Res Commun (1977) 1.54

Binding of insulin to isolated nuclei. Proc Natl Acad Sci U S A (1976) 1.34

A monoclonal antibody to human insulin receptor. Biochem Biophys Res Commun (1982) 1.33

Insulin receptor: structure and function. Endocr Rev (1981) 1.18

Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor. Proc Natl Acad Sci U S A (1976) 1.16

Characterization of insulin-like actions of anti-insulin receptor antibodies. Effects on insulin binding, insulin degradation, and glycogen synthesis in isolated rat hepatocytes. J Biol Chem (1980) 0.98

Insulin action. Am J Med (1981) 0.98

Insulin-like stimulatory effect of human immunoglobulin G on adipocyte lipogenesis. Diabetes (1981) 0.94

Structure of the insulin receptor of the cultured human lymphoblastoid cell IM-9. Evidence suggesting that two subunits are required for insulin binding. J Biol Chem (1982) 0.89

The insulin receptor in vertebrates is functionally more conserved during evolution than insulin itself. Endocrinology (1979) 0.89

Action of insulin analogues on cultured human fibroblasts reflects biological potency. Life Sci (1976) 0.82

Specificities of rabbit anti-human insulin receptor antibodies. J Clin Lab Immunol (1979) 0.80

Production of antibodies that inhibit the binding of insulin to its receptor. Biochem Biophys Res Commun (1981) 0.79

The role of insulin receptors and receptor antibodies in states of altered insulin action. Proc Soc Exp Biol Med (1979) 0.78

Stimulatory effects of prolactin and anti-prolactin receptor serum on prolactin binding sites in rat liver cells in suspension culture. Biochem Biophys Res Commun (1982) 0.78

Articles by these authors

Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79

The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45

Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem (1996) 6.35

Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature (1985) 3.75

Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1998) 3.66

Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (1987) 3.52

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol (1999) 3.50

Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99

Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem (1996) 2.99

Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem (1998) 2.93

Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J (1995) 2.92

Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem (1999) 2.89

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64

Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochem Biophys Res Commun (1997) 2.55

Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem (1990) 2.35

Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem (1999) 2.28

Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes (2001) 2.21

On the conformational stability of globular proteins. The effects of various electrolytes and nonelectrolytes on the thermal ribonuclease transition. J Biol Chem (1965) 2.17

Insulin receptor: evidence that it is a protein kinase. Science (1983) 2.17

Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem (1999) 2.13

Electrostatic enhancement of diffusion-controlled protein-protein association: comparison of theory and experiment on barnase and barstar. J Mol Biol (1998) 2.13

Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J (1997) 2.09

Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry (1997) 2.00

Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care (1990) 1.90

Ras p21 as a potential mediator of insulin action in Xenopus oocytes. Science (1987) 1.87

Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev (2000) 1.85

Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem (1988) 1.83

Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80

Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology (1984) 1.79

An unusual active site identified in a family of zinc metalloendopeptidases. Proc Natl Acad Sci U S A (1992) 1.74

Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem (1997) 1.73

Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. Proc Natl Acad Sci U S A (1987) 1.73

Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70

Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. J Cell Biol (1985) 1.68

Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem (2001) 1.67

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene (1999) 1.66

Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1985) 1.66

Surface markers and prognostic factors in acute lymphoblastic leukemia. N Engl J Med (1976) 1.64

Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res (1999) 1.63

Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis (2010) 1.62

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes (2000) 1.62

Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol (2008) 1.61

Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport. J Biol Chem (1972) 1.56

A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes (1999) 1.56

Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat. J Biol Chem (1974) 1.55

DNA synthesis in human fibroblasts: stimulation by insulin and by nonsuppressible insulin-like activity (NSILA-S). J Clin Endocrinol Metab (1974) 1.53

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51

Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes (1998) 1.50

Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. J Biol Chem (1990) 1.49

Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol (2012) 1.48

Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family. J Biol Chem (2001) 1.48

Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man. Recent Prog Horm Res (1975) 1.47

Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev (1993) 1.45

Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly. J Biol Chem (1981) 1.43

Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells. Endocrinology (1993) 1.42

Bile secretory apparatus: evidence for a vesicular transport mechanism for proteins in the rat, using horseradish peroxidase and [125I]insulin. Gastroenterology (1980) 1.42

The insulin-pancreatic acinar axis. Diabetes (1985) 1.42

Neutrophil migration during endotoxemia. J Leukoc Biol (1999) 1.42

Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem (1980) 1.41

Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. J Biol Chem (1988) 1.41

Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun (1999) 1.41

Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci U S A (1986) 1.40

Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ (2000) 1.38

Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. Proc Natl Acad Sci U S A (1995) 1.37

Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest (1992) 1.36

The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J Biol Chem (1991) 1.35

Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. Science (1988) 1.34

Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J Biol Chem (1993) 1.34

Binding of insulin to isolated nuclei. Proc Natl Acad Sci U S A (1976) 1.34

The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J Biol Chem (1999) 1.32

Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J Biol Chem (1990) 1.31

Insulin receptor expression and function in human breast cancer cell lines. Cancer Res (1992) 1.31

Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene. J Biol Chem (1998) 1.30

Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J (1998) 1.29

Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun (2001) 1.28

Role of disulfide interchange enzyme in immunoglobulin synthesis. Biochemistry (1981) 1.28

A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem (1992) 1.27

Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J (2001) 1.27

Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist. Biochem Biophys Res Commun (1983) 1.27

Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus. J Biol Chem (1994) 1.26

Entry of insulin into human cultured lymphocytes: electron microscope autoradiographic analysis. Science (1978) 1.25

Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc Natl Acad Sci U S A (1986) 1.23

Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem (1988) 1.23

Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance. Biochem Biophys Res Commun (1973) 1.23

Mechanisms of receptor-mediated transmembrane communication. Cold Spring Harb Symp Quant Biol (1986) 1.22

Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia (2007) 1.21

The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol (1999) 1.20

Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem Biophys Res Commun (1994) 1.19

Dynamic aspects of native DNA structure: kinetics of the formaldehyde reaction with calf thymus DNA. J Mol Biol (1971) 1.19